Composition
- Active ingredients
- BELANTAMAB MAFODOTIN-BLMF 70MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761440.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Blenrep
- Active substance
- belantamab mafodotin-blmf
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Glaxosmithkline LLC
- Status
- Prescription
- FDA approval
- 23 Oct 2025
- Application
- BLA761440-001